Scientists test new ADHD pill formulas in healthy volunteers
NCT ID NCT07253441
Summary
This early-stage study tested different capsule versions of an experimental drug called centanafadine, which is being developed for ADHD. Researchers gave the pills to 174 healthy adults to see if different capsule strengths worked the same, if food affected absorption, and how the new capsules compared to an older tablet form. The main goal was to understand how the body processes these different pill formulas to help design the final product.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ICON Lenexa
Lenexa, Kansas, 66219, United States
-
ICON Salt Lake City
Millcreek, Utah, 84124, United States
Conditions
Explore the condition pages connected to this study.